Poly(ɛ-caprolactone)–poly(ethylene glycol)–poly(ɛ-caprolactone) (PCL–PEG–PCL) nanoparticles for honokiol delivery in vitro
Authors:
- Lan ZhengLZLan Zheng
- XinYun PengXPXinYun Peng
- Gang GuoGGGang Guo
- ZhiYong QianZQZhiYong Qian
- 1 June 2009
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 375 (1-2) , 170-176
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- New frontiers in nanotechnology for cancer treatmentUrologic Oncology: Seminars and Original Investigations, 2008
- Rapid purification and scale-up of honokiol and magnolol using high-capacity high-speed counter-current chromatographyJournal of Chromatography A, 2007
- Preparation of anionic poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) copolymeric nanoparticles as basic protein antigen carrierGrowth Factors, 2007
- A Phase I and Pharmacokinetic Study of Paclitaxel Poliglumex (XYOTAX), Investigating Both 3-Weekly and 2-Weekly SchedulesClinical Cancer Research, 2005
- The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cellsBlood, 2005
- The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemiaLeukemia & Lymphoma, 2005
- Cancer nanotechnology: opportunities and challengesNature Reviews Cancer, 2005
- Drug Delivery Systems: Entering the MainstreamScience, 2004
- Honokiol, a Small Molecular Weight Natural Product, Inhibits Angiogenesis in Vitro and Tumor Growth in VivoJournal of Biological Chemistry, 2003
- Preparation, characterization, and drug release behaviors of drug nimodipine‐loaded poly(ε‐caprolactone)‐poly(ethylene oxide)‐poly(ε‐caprolactone) amphiphilic triblock copolymer micellesJournal of Pharmaceutical Sciences, 2002